http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 09 Mar 2026 06:18:53 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+PT+Change/Charles+River+Labs+%28CRL%29+PT+Raised+to+%24197+at+Baird/26128499.html Baird analyst Eric Coldwell raised the price target on Charles River Labs (NYSE: CRL) to $197.00 (from $193.00) while maintaining a Outperform rating. http://www.streetinsider.com/Analyst+PT+Change/Charles+River+Labs+%28CRL%29+PT+Raised+to+%24197+at+Baird/26128499.html Mon, 09 Mar 2026 06:18:53 -0400 CRL http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Mar+04++Filed+by%3A+Girshick+Birgit/26120361.html si-local-file:///var/storage/secattach/20260305/26120361.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Mar+04++Filed+by%3A+Girshick+Birgit/26120361.html Thu, 05 Mar 2026 17:18:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Mar+04++Filed+by%3A+Girshick+Birgit/26120361.html si-local-file:///var/storage/secattach/20260305/26120361.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Mar+04++Filed+by%3A+Girshick+Birgit/26120361.html Thu, 05 Mar 2026 17:18:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Mar+02++Filed+by%3A+FOSTER+JAMES+C/26112119.html si-local-file:///var/storage/secattach/20260304/26112119.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Mar+02++Filed+by%3A+FOSTER+JAMES+C/26112119.html Wed, 04 Mar 2026 16:42:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Mar+02++Filed+by%3A+FOSTER+JAMES+C/26112119.html si-local-file:///var/storage/secattach/20260304/26112119.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Mar+02++Filed+by%3A+FOSTER+JAMES+C/26112119.html Wed, 04 Mar 2026 16:42:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Mar+03++Filed+by%3A+LaPlume+Joseph+W/26112020.html si-local-file:///var/storage/secattach/20260304/26112020.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Mar+03++Filed+by%3A+LaPlume+Joseph+W/26112020.html Wed, 04 Mar 2026 16:39:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Mar+03++Filed+by%3A+LaPlume+Joseph+W/26112020.html si-local-file:///var/storage/secattach/20260304/26112020.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Mar+03++Filed+by%3A+LaPlume+Joseph+W/26112020.html Wed, 04 Mar 2026 16:39:00 -0400 CRL O.00066481 http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including: </p><ul class="bwlistdisc"> <li> TD Cowen 46th Annual Health Care Conference on Tuesday, March 3rd, at 9:50 a.m. ET; and </li> <li> Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10th, at 10:00 a.m. ET. </li> </ul><p> Management will present an overview of Charles River’s strategic focus, business developments, and recent trends. </p><p> A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fir.criver.com%2F&amp;esheet=54434660&amp;newsitemid=20260302232011&amp;lan=en-US&amp;anchor=ir.criver.com&amp;index=1&amp;md5=2cad333aedb62985e75c74a499d1345c" shape="rect">ir.criver.com</a>. A http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html Mon, 02 Mar 2026 08:00:00 -0400 A.50100012 CRL O.00066481 O.07579093 http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including: </p><ul class="bwlistdisc"> <li> TD Cowen 46th Annual Health Care Conference on Tuesday, March 3rd, at 9:50 a.m. ET; and </li> <li> Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10th, at 10:00 a.m. ET. </li> </ul><p> Management will present an overview of Charles River’s strategic focus, business developments, and recent trends. </p><p> A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fir.criver.com%2F&amp;esheet=54434660&amp;newsitemid=20260302232011&amp;lan=en-US&amp;anchor=ir.criver.com&amp;index=1&amp;md5=2cad333aedb62985e75c74a499d1345c" shape="rect">ir.criver.com</a>. A http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html Mon, 02 Mar 2026 08:00:00 -0400 A.50100012 CRL O.00066481 O.07579093 http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including: </p><ul class="bwlistdisc"> <li> TD Cowen 46th Annual Health Care Conference on Tuesday, March 3rd, at 9:50 a.m. ET; and </li> <li> Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10th, at 10:00 a.m. ET. </li> </ul><p> Management will present an overview of Charles River’s strategic focus, business developments, and recent trends. </p><p> A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fir.criver.com%2F&amp;esheet=54434660&amp;newsitemid=20260302232011&amp;lan=en-US&amp;anchor=ir.criver.com&amp;index=1&amp;md5=2cad333aedb62985e75c74a499d1345c" shape="rect">ir.criver.com</a>. A http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html Mon, 02 Mar 2026 08:00:00 -0400 A.50100012 CRL O.00066481 O.07579093 http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including: </p><ul class="bwlistdisc"> <li> TD Cowen 46th Annual Health Care Conference on Tuesday, March 3rd, at 9:50 a.m. ET; and </li> <li> Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10th, at 10:00 a.m. ET. </li> </ul><p> Management will present an overview of Charles River’s strategic focus, business developments, and recent trends. </p><p> A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fir.criver.com%2F&amp;esheet=54434660&amp;newsitemid=20260302232011&amp;lan=en-US&amp;anchor=ir.criver.com&amp;index=1&amp;md5=2cad333aedb62985e75c74a499d1345c" shape="rect">ir.criver.com</a>. A http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html Mon, 02 Mar 2026 08:00:00 -0400 A.50100012 CRL O.00066481 O.07579093 http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including: </p><ul class="bwlistdisc"> <li> TD Cowen 46th Annual Health Care Conference on Tuesday, March 3rd, at 9:50 a.m. ET; and </li> <li> Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10th, at 10:00 a.m. ET. </li> </ul><p> Management will present an overview of Charles River’s strategic focus, business developments, and recent trends. </p><p> A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fir.criver.com%2F&amp;esheet=54434660&amp;newsitemid=20260302232011&amp;lan=en-US&amp;anchor=ir.criver.com&amp;index=1&amp;md5=2cad333aedb62985e75c74a499d1345c" shape="rect">ir.criver.com</a>. A http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html Mon, 02 Mar 2026 08:00:00 -0400 A.50100012 CRL O.00066481 O.07579093 http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including: </p><ul class="bwlistdisc"> <li> TD Cowen 46th Annual Health Care Conference on Tuesday, March 3rd, at 9:50 a.m. ET; and </li> <li> Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10th, at 10:00 a.m. ET. </li> </ul><p> Management will present an overview of Charles River’s strategic focus, business developments, and recent trends. </p><p> A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fir.criver.com%2F&amp;esheet=54434660&amp;newsitemid=20260302232011&amp;lan=en-US&amp;anchor=ir.criver.com&amp;index=1&amp;md5=2cad333aedb62985e75c74a499d1345c" shape="rect">ir.criver.com</a>. A http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html Mon, 02 Mar 2026 08:00:00 -0400 A.50100012 CRL O.00066481 O.07579093 http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including: </p><ul class="bwlistdisc"> <li> TD Cowen 46th Annual Health Care Conference on Tuesday, March 3rd, at 9:50 a.m. ET; and </li> <li> Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10th, at 10:00 a.m. ET. </li> </ul><p> Management will present an overview of Charles River’s strategic focus, business developments, and recent trends. </p><p> A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fir.criver.com%2F&amp;esheet=54434660&amp;newsitemid=20260302232011&amp;lan=en-US&amp;anchor=ir.criver.com&amp;index=1&amp;md5=2cad333aedb62985e75c74a499d1345c" shape="rect">ir.criver.com</a>. A http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html Mon, 02 Mar 2026 08:00:00 -0400 A.50100012 CRL O.00066481 O.07579093 http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including: </p><ul class="bwlistdisc"> <li> TD Cowen 46th Annual Health Care Conference on Tuesday, March 3rd, at 9:50 a.m. ET; and </li> <li> Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10th, at 10:00 a.m. ET. </li> </ul><p> Management will present an overview of Charles River’s strategic focus, business developments, and recent trends. </p><p> A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fir.criver.com%2F&amp;esheet=54434660&amp;newsitemid=20260302232011&amp;lan=en-US&amp;anchor=ir.criver.com&amp;index=1&amp;md5=2cad333aedb62985e75c74a499d1345c" shape="rect">ir.criver.com</a>. A http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+to+Present+at+TD+Cowen+and+Barclays+Conferences/26087226.html Mon, 02 Mar 2026 08:00:00 -0400 A.50100012 CRL O.00066481 O.07579093 http://www.streetinsider.com/Analyst+PT+Change/Charles+River+Labs+%28CRL%29+PT+Raised+to+%24175+at+UBS/26055975.html UBS analyst Dan Leonard raised the price target on Charles River Labs (NYSE: CRL) to $175.00 (from $170.00) while maintaining a Neutral rating. http://www.streetinsider.com/Analyst+PT+Change/Charles+River+Labs+%28CRL%29+PT+Raised+to+%24175+at+UBS/26055975.html Wed, 25 Feb 2026 08:46:07 -0400 CRL http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CHARLES+RIVER+LABORATORI++For%3A+Feb+25/26055340.html si-local-file:///var/storage/secattach/20260225/26055340.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CHARLES+RIVER+LABORATORI++For%3A+Feb+25/26055340.html Wed, 25 Feb 2026 07:34:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CHARLES+RIVER+LABORATORI++For%3A+Feb+25/26055340.html si-local-file:///var/storage/secattach/20260225/26055340.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++CHARLES+RIVER+LABORATORI++For%3A+Feb+25/26055340.html Wed, 25 Feb 2026 07:34:00 -0400 CRL O.00066481 http://www.streetinsider.com/Corporate+News/Charles+River+Labs+to+divest+CDMO+and+European+discovery+assets/26055149.html <p>Charles River Laboratories International (NYSE: CRL) announced it has signed definitive agreements to sell its CDMO and Cell Solutions businesses as well as certain European Discovery Services assets in separate transactions.</p><p>The company will divest its CDMO and Cell Solutions businesses to GI Partners primarily for future contingent performance-based payments. The businesses generated combined annual revenue of $143 million in 2025, including $117 million in the Manufacturing Solutions segment and $26 million in the Research Models and Services segment. The transaction includes CDMO sites in Tennessee, Maryland, and the United Kingdom, plus a Cell Solutions site in California.</p><p>Separately, Charles River will http://www.streetinsider.com/Corporate+News/Charles+River+Labs+to+divest+CDMO+and+European+discovery+assets/26055149.html Wed, 25 Feb 2026 07:01:07 -0400 CRL http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+Provides+Update+on+Planned+Divestitures/26055062.html <p class="bwalignc"> <b>– Announces Signing of Definitive Agreements to Divest the CDMO and Cell Solutions Businesses and Certain European Discovery Services Assets –</b> </p><p class="bwalignc"> <b>– Updates 2026 Financial Guidance –</b> </p> <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has signed definitive agreements to sell certain European Discovery Services assets as well as the CDMO and Cell Solutions businesses in separate transactions. </p><p> James C. Foster, Chair, President and Chief Executive Officer, said, “We are pleased to announce these planned divestitures today to demonstrate our continued progress on the actions outlined as part of the comprehensive strategic http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+Provides+Update+on+Planned+Divestitures/26055062.html Wed, 25 Feb 2026 07:00:00 -0400 CRL O.00066481 http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+Provides+Update+on+Planned+Divestitures/26055062.html <p class="bwalignc"> <b>– Announces Signing of Definitive Agreements to Divest the CDMO and Cell Solutions Businesses and Certain European Discovery Services Assets –</b> </p><p class="bwalignc"> <b>– Updates 2026 Financial Guidance –</b> </p> <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has signed definitive agreements to sell certain European Discovery Services assets as well as the CDMO and Cell Solutions businesses in separate transactions. </p><p> James C. Foster, Chair, President and Chief Executive Officer, said, “We are pleased to announce these planned divestitures today to demonstrate our continued progress on the actions outlined as part of the comprehensive strategic http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+Provides+Update+on+Planned+Divestitures/26055062.html Wed, 25 Feb 2026 07:00:00 -0400 CRL O.00066481 http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+Provides+Update+on+Planned+Divestitures/26055062.html <p class="bwalignc"> <b>– Announces Signing of Definitive Agreements to Divest the CDMO and Cell Solutions Businesses and Certain European Discovery Services Assets –</b> </p><p class="bwalignc"> <b>– Updates 2026 Financial Guidance –</b> </p> <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has signed definitive agreements to sell certain European Discovery Services assets as well as the CDMO and Cell Solutions businesses in separate transactions. </p><p> James C. Foster, Chair, President and Chief Executive Officer, said, “We are pleased to announce these planned divestitures today to demonstrate our continued progress on the actions outlined as part of the comprehensive strategic http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+Provides+Update+on+Planned+Divestitures/26055062.html Wed, 25 Feb 2026 07:00:00 -0400 CRL O.00066481 http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+Provides+Update+on+Planned+Divestitures/26055062.html <p class="bwalignc"> <b>– Announces Signing of Definitive Agreements to Divest the CDMO and Cell Solutions Businesses and Certain European Discovery Services Assets –</b> </p><p class="bwalignc"> <b>– Updates 2026 Financial Guidance –</b> </p> <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has signed definitive agreements to sell certain European Discovery Services assets as well as the CDMO and Cell Solutions businesses in separate transactions. </p><p> James C. Foster, Chair, President and Chief Executive Officer, said, “We are pleased to announce these planned divestitures today to demonstrate our continued progress on the actions outlined as part of the comprehensive strategic http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+Provides+Update+on+Planned+Divestitures/26055062.html Wed, 25 Feb 2026 07:00:00 -0400 CRL O.00066481 http://www.streetinsider.com/Analyst+PT+Change/Charles+River+Labs+%28CRL%29+PT+Lowered+to+%24235+at+TD+Cowen/26033844.html TD Cowen analyst Charles Rhyee lowered the price target on Charles River Labs (NYSE: CRL) to $235.00 (from $251.00) while maintaining a rating. http://www.streetinsider.com/Analyst+PT+Change/Charles+River+Labs+%28CRL%29+PT+Lowered+to+%24235+at+TD+Cowen/26033844.html Fri, 20 Feb 2026 09:33:20 -0400 CRL http://www.streetinsider.com/Analyst+PT+Change/Charles+River+Labs+%28CRL%29+PT+Lowered+to+%24175+at+Mizuho/26032911.html Mizuho analyst Ann Hynes lowered the price target on Charles River Labs (NYSE: CRL) to $175.00 (from $215.00) while maintaining a Neutral rating. http://www.streetinsider.com/Analyst+PT+Change/Charles+River+Labs+%28CRL%29+PT+Lowered+to+%24175+at+Mizuho/26032911.html Fri, 20 Feb 2026 07:13:32 -0400 CRL